← Back to Search

Structured Exercise Program for Kidney Transplant Candidates (SPaRKT Trial)

N/A
Recruiting
Led By Anoop Sheshadri, MD, MAS
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Having a living donor kidney
On hemodialysis or peritoneal dialysis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 8 weeks (post-program completion), approximately 20 weeks (3-months post-kt)
Awards & highlights

SPaRKT Trial Summary

This trial is looking at whether or not a structured exercise program can help older patients with end-stage kidney disease who are waiting for a kidney transplant. The hope is that the exercise program will improve their physical performance and quality of life.

Who is the study for?
This trial is for older adults (50+) with end-stage kidney disease on dialysis, who have a living donor for a kidney transplant and are not currently in an exercise program. They must have limited physical abilities (SPPB score ≤ 10), and access to both telephone and internet. Non-English speakers cannot participate.Check my eligibility
What is being tested?
The study tests an 8-week home-based structured exercise program designed for older patients awaiting kidney transplants, involving caregivers in the process. It compares the effects of this program plus usual care against usual care alone on patients' physical performance, activity levels, quality of life, and post-transplant hospitalization days.See study design
What are the potential side effects?
Since this trial involves an exercise program rather than medication, side effects may include typical exercise-related issues such as muscle soreness or fatigue. However, these should be mild and temporary as the program is tailored to individuals with limited physical ability.

SPaRKT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a living donor for a kidney transplant.
Select...
I am currently on dialysis.
Select...
I am 50 years old or older.
Select...
My physical ability score is 10 or less.

SPaRKT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 8 weeks (post-program completion), approximately 20 weeks (3-months post-kt)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 8 weeks (post-program completion), approximately 20 weeks (3-months post-kt) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Short Physical Performance Battery (SPPB)
Change in Step Count
Secondary outcome measures
Change in 6 minute walk distance (6MWD)
Change in Center for Epidemiological Studies- Depression (CES-D) score
Change in Dialysis Symptoms Index (DSI) score
+6 more

SPaRKT Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Weekly CoachingActive Control1 Intervention
Weekly coaching per the SPaRKT protocol with titrated increases in physical activity and resistance exercise
Group II: Weekly Coaching + Caregiver ParticipationActive Control1 Intervention
Weekly coaching per the SPaRKT protocol with titrated increases in physical activity and resistance exercise with the addition of caregiver participation to promote adherence and engagement
Group III: Usual CarePlacebo Group1 Intervention
Patients randomized to usual care will receive recommendations for exercise based on the Surgeon General's recommendations for physical activity among adults as well as the American Heart Association and American College of Sports Medicine recommendations for older individuals or individuals with chronic conditions. These guidelines are applicable to this patient population. Patients will not receive coaching but will receive accelerometers to obtain data for comparison to the intervention groups at each time point (baseline, 8 weeks, and 3 months post-KT).

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,506 Previous Clinical Trials
15,238,419 Total Patients Enrolled
Anoop Sheshadri, MD, MASPrincipal InvestigatorUniversity of California, San Francisco

Media Library

Structured Program of exercise for Recipients of Kidney Transplantation Clinical Trial Eligibility Overview. Trial Name: NCT04954690 — N/A
Kidney Complication Research Study Groups: Usual Care, Weekly Coaching, Weekly Coaching + Caregiver Participation
Kidney Complication Clinical Trial 2023: Structured Program of exercise for Recipients of Kidney Transplantation Highlights & Side Effects. Trial Name: NCT04954690 — N/A
Structured Program of exercise for Recipients of Kidney Transplantation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04954690 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many subjects are actively participating in this research?

"Affirmative. According to clinicaltrials.gov, this medical experiment was initially posted on November 1st 2021 and is presently recruiting participants. As of now, 136 patients need to be recruited from one medical centre."

Answered by AI

What are the primary goals of this research endeavor?

"This trial seeks to measure Change in Step Count as the primary objective, with secondary objectives including evaluation of Grip Strength (determined by a handheld dynamometer), Short Form-36 score, and Center for Epidemiological Studies- Depression rating. The assessment period spans from baseline to 8 weeks after program completion and 20 weeks post-KT."

Answered by AI

Are there vacancies available for individuals wishing to join the trial?

"Affirmative. According to clinicaltrials.gov, this research study is currently looking for enrollees and was first posted on November 1st 2021 with the latest update made on 8th of that same month. 136 patients are expected from one clinical site."

Answered by AI
~82 spots leftby Jul 2026